about
Review of the use of Topiramate for treatment of psychiatric disordersThe search for medications to treat stimulant dependenceGABA and glutamate in the human brainRegional metabolite levels and turnover in the awake rat brain under the influence of nicotine.Behaviour, cognition and epilepsy.Recent advances in magnetic resonance neurospectroscopy.Topiramate in the prophylactic treatment of cluster headache.AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic futureGABA-based evaluation of neurologic conditions: MR spectroscopy.Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder.New medications for the treatment of cocaine dependence.Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia.The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.GABAergic dysfunction in mood disorders.Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS.Neuroimaging of epilepsy: therapeutic implications.Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Topiramate for the treatment of epilepsy and other nervous system disorders.Approaches to the development of medications for the treatment of methamphetamine dependence.Levetiracetam has no acute effects on brain gamma-aminobutyric acid levels.Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.Psychopharmacology of topiramate: from epilepsy to bipolar disorder.Efficacy and Safety of Topiramate for Essential Tremor: A Meta-Analysis of Randomized Controlled TrialsAcute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behaviorTopiramate and cognitive impairment: evidence and clinical implications.Topiramate in Migraine Prevention: A 2016 Perspective.Reduced gamma-aminobutyric acid is associated with emotional and behavioral problems in Prader-Willi syndrome.Topiramate rapidly raises brain GABA in epilepsy patients.Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.Treatment of cluster headache with topiramate: effects and side-effects in five patients.GABA X2 multiplet measured pre- and post-administration of vigabatrin in human brain.Topiramate selectively decreases intracortical excitability in human motor cortex.A proton magnetic resonance spectroscopy study of metabolites in the occipital lobes in epilepsy.Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy.Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina.Topiramate in the treatment of chronic migraine.SUNCT syndrome successfully treated with topiramate: case reports.Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system.Effect of topiramate on seizures and respiratory dysrhythmia in Rett syndrome.
P2860
Q24523918-878AE70C-6220-41D9-BC88-44A772C9F75FQ24655160-EFEC1C48-1F02-49DA-9590-F45A28F6ACFAQ28216691-22A23BCF-9291-40D2-A287-D850AC2E43D7Q30475326-9DD37371-3F7C-4F82-AA7D-CE6CAB763461Q31026691-DE817D38-19B6-4742-9D03-75486C8B59CCQ31117145-7781F734-DF66-4BED-AD7F-0FBF6726A6EDQ33967443-464749CC-16F7-4818-9B33-10778F3386FAQ33995795-66C34B75-D8AD-4EDD-90CD-41CDF5255BFAQ34135715-DB2A5783-F529-43C8-91B7-CE68E17E2C2EQ34146222-5D129837-C4B9-4356-8C22-7E852B24EF50Q34152650-DC463504-6DC6-49FA-B403-BD1CB22D253CQ34570674-E79FD036-9AAB-4DD9-A082-F8ED1E6542F2Q34576250-CC516BB2-B20E-409C-92DB-5D2A6AEA5BA6Q34653718-6BE27B7F-CE8E-4FC6-83A4-38E0560078B8Q35187929-1A13BED4-B515-4E6D-AC50-E5358C20C000Q35531546-C40DC3D1-4EFE-4B7B-BAA7-4B5B691A6364Q36129741-054A3532-F918-4491-ACC4-40717EEBFEF1Q36372867-DBB80EF7-FF43-4D11-A374-6C64E8DD6FAEQ36390841-E590550C-CB1A-400B-8465-4A8058F0180AQ36817245-DE2BC7B6-87D0-4590-886D-73A918698D29Q36854991-884E6325-5D37-4CA8-B5DD-707701706472Q37164665-D2492B81-E027-4779-849E-466DAE18100EQ37166152-DF47C77C-72A7-4724-9F19-CBE5BBD65D98Q37176201-9289BF75-6C19-4B78-9F05-AC7802805376Q37350134-0D97FF42-7E83-4B7F-B325-5744B2163337Q38235953-AA6D5B0D-6134-4AF3-A0AE-2DC670ED071BQ39024628-7DDE4E11-EBB7-44F7-9B89-923FA3327412Q39659093-45708DBD-0F0D-4BDA-B943-105B7B49C1A6Q43664156-0B595994-0E6B-4B0C-9A7B-207D24949117Q43817929-478B522B-51BB-48AE-9182-F774C6F8F662Q44016420-5E83B314-F23C-48F5-940B-6677E6797E40Q44157545-D2E9BAEF-C87F-4BD2-8EC8-75AB2E638E50Q44169556-FE1AD6DB-F148-4333-A0AB-32D388CE4187Q44393946-80254B22-7097-4936-B9E2-F952BA0F6949Q44444516-AEFA334C-D228-446D-AACA-28D7A47C31FFQ44489274-ADE240BB-70E4-421E-BBA0-91B53614EB80Q44597128-C3101536-BCFB-4E54-B11E-000D2A12BE11Q44776570-347AC8B2-DF7A-4EE0-AF15-6D2FEFF75BE4Q44856293-516C4A76-D858-47EC-BC21-1F3209FBDBB3Q45191353-49A67D49-1A6E-4D35-8833-5D537626D687
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Topiramate increases cerebral GABA in healthy humans.
@en
Topiramate increases cerebral GABA in healthy humans.
@nl
type
label
Topiramate increases cerebral GABA in healthy humans.
@en
Topiramate increases cerebral GABA in healthy humans.
@nl
prefLabel
Topiramate increases cerebral GABA in healthy humans.
@en
Topiramate increases cerebral GABA in healthy humans.
@nl
P2093
P356
P1433
P1476
Topiramate increases cerebral GABA in healthy humans.
@en
P2093
H Hetherington
R Kuzniecky
P304
P356
10.1212/WNL.51.2.627
P407
P577
1998-08-01T00:00:00Z